Compare $ESLA vs $JSPR | Chartloom

Compare

$ESLA vs $JSPR

Estrella Immunopharma Inc · Jasper Therapeutics Inc

ESLA

Estrella Immunopharma Inc

JSPR

Jasper Therapeutics Inc

Compare $ESLA vs $JSPR

Comparing Estrella Immunopharma Inc and Jasper Therapeutics Inc

ESLAEstrella Immunopharma Inc

JSPRJasper Therapeutics Inc

ESLAEstrella Immunopharma Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-70.5%

52W performance

-68.5%

FCF yield

-53.2%

JSPRJasper Therapeutics Inc

Market cap

$19M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.0%

52W performance

-76.2%

FCF yield

-318.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ESLA

JSPR

Detailed metrics comparison

ESLA

Estrella Immunopharma Inc

JSPR

Jasper Therapeutics Inc

Market Cap

ESLA$18M

JSPR$19M

Enterprise Value

ESLA$17M

JSPR$12M

Price

ESLA$0.41

JSPR$0.57

P/E Ratio

ESLAN/A

JSPRN/A

P/S Ratio

ESLA0.00x

JSPR0.00x

EV/Sales

ESLA0.00x

JSPR0.00x

EV/EBITDA

ESLA0.00x

JSPR0.00x

P/B Ratio

ESLA141.63x

JSPR13.31x

P/FCF Ratio

ESLAN/A

JSPRN/A

EV/FCF

ESLA-1.86x

JSPR-0.19x

PEG Ratio

ESLAN/A

JSPRN/A

Forward P/E (NTM)

ESLAN/A

JSPRN/A

Forward P/S (NTM)

ESLAN/A

JSPRN/A

Revenue (TTM)

ESLA$0

JSPR$0

Revenue Growth (YoY)

ESLAN/A

JSPRN/A

Forward Rev Growth

ESLA0.0%

JSPR-81.1%

Gross Margin (TTM)

ESLA0.0%

JSPR0.0%

Operating Margin (TTM)

ESLA0.0%

JSPR0.0%

EBITDA Margin (TTM)

ESLA0.0%

JSPR0.0%

Net Margin (TTM)

ESLA0.0%

JSPR0.0%

FCF Margin (TTM)

ESLAN/A

JSPRN/A

Net Income (TTM)

ESLA$-10M

JSPR$-32M

FCF (TTM)

ESLA$-9M

JSPR$-60M

EPS (TTM)

ESLA-$0.23

JSPR-$1.11

ROE (TTM)

ESLA-25911.0%

JSPR-61887.0%

ROA (TTM)

ESLA-32876.0%

JSPR-10067.0%

ROIC (TTM)

ESLA-25911.0%

JSPR-61887.0%

Cash

ESLA$147K

JSPR$7M

Debt

ESLA$0

JSPR$0

Net Cash/Debt

ESLA$147K

JSPR$7M

Current Ratio (TTM)

ESLA0.20x

JSPR1.48x

Quick Ratio (TTM)

ESLA0.02x

JSPR1.02x

Debt/Equity (TTM)

ESLA0.00x

JSPR0.00x

Debt/Assets (TTM)

ESLA0.0%

JSPR0.0%

Interest Coverage (TTM)

ESLAN/A

JSPRN/A

Net Debt/EBITDA (TTM)

ESLA0.00x

JSPR0.00x

Beta

ESLA0.98

JSPR3.37

52W Performance

ESLA-68.5%

JSPR-76.2%

YTD Performance

ESLA-70.5%

JSPR-69.0%

% from 52W High

ESLA-87.0%

JSPR-78.8%

% from 52W Low

ESLA33.0%

JSPR81.0%

Asset Turnover (TTM)

ESLA0.00x

JSPR0.00x

FCF Yield (TTM)

ESLA-53.2%

JSPR-318.0%

Earnings Yield (TTM)

ESLA-56.8%

JSPR-167.5%

Dividend Yield (TTM)

ESLAN/A

JSPRN/A

Rule of 40

ESLA0.0

JSPR0.0

EV/GP/RG

ESLAN/A

JSPRN/A

Ticker research

View ESLA research View JSPR research

Metric	ESLA Estrella Immunopharma Inc	JSPR Jasper Therapeutics Inc
Market & Valuation
Market Cap	$18M	$19M
Enterprise Value	$17M	$12M
Price	$0.41	$0.57
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	141.63x	13.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.86x	-0.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	-81.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-32M
FCF (TTM)	$-9M	$-60M
EPS (TTM)	-$0.23	-$1.11
ROE (TTM)	-25911.0%	-61887.0%
ROA (TTM)	-32876.0%	-10067.0%
ROIC (TTM)	-25911.0%	-61887.0%
Financial Health
Cash	$147K	$7M
Debt	$0	$0
Net Cash/Debt	$147K	$7M
Current Ratio (TTM)	0.20x	1.48x
Quick Ratio (TTM)	0.02x	1.02x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.98	3.37
52W Performance	-68.5%	-76.2%
YTD Performance	-70.5%	-69.0%
% from 52W High	-87.0%	-78.8%
% from 52W Low	33.0%	81.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-53.2%	-318.0%
Earnings Yield (TTM)	-56.8%	-167.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ESLA research	View JSPR research

Valuation

P/S Ratio

ESLA

0.00x

JSPR

0.00x

EV/FCF

ESLA

-1.86x

JSPR

-0.19x

Growth & revenue

Forward Revenue Growth

ESLA

0.0%

JSPR

-81.1%

Profitability & performance

Gross Margin

ESLA

0.0%

JSPR

0.0%

ROE

ESLA

-25911.0%

JSPR

-61887.0%

FCF Yield %

ESLA

-53.2%

JSPR

-318.0%

52-Week Performance

ESLA

-68.5%

JSPR

-76.2%

Detailed metrics comparison

ESLA

Estrella Immunopharma Inc

JSPR

Jasper Therapeutics Inc

Market Cap

ESLA$18M

JSPR$19M

Enterprise Value

ESLA$17M

JSPR$12M

Price

ESLA$0.41

JSPR$0.57

P/E Ratio

ESLAN/A

JSPRN/A

P/S Ratio

ESLA0.00x

JSPR0.00x

EV/Sales

ESLA0.00x

JSPR0.00x

EV/EBITDA

ESLA0.00x

JSPR0.00x

P/B Ratio

ESLA141.63x

JSPR13.31x

P/FCF Ratio

ESLAN/A

JSPRN/A

EV/FCF

ESLA-1.86x

JSPR-0.19x

PEG Ratio

ESLAN/A

JSPRN/A

Forward P/E (NTM)

ESLAN/A

JSPRN/A

Forward P/S (NTM)

ESLAN/A

JSPRN/A

Revenue (TTM)

ESLA$0

JSPR$0

Revenue Growth (YoY)

ESLAN/A

JSPRN/A

Forward Rev Growth

ESLA0.0%

JSPR-81.1%

Gross Margin (TTM)

ESLA0.0%

JSPR0.0%

Operating Margin (TTM)

ESLA0.0%

JSPR0.0%

EBITDA Margin (TTM)

ESLA0.0%

JSPR0.0%

Net Margin (TTM)

ESLA0.0%

JSPR0.0%

FCF Margin (TTM)

ESLAN/A

JSPRN/A

Net Income (TTM)

ESLA$-10M

JSPR$-32M

FCF (TTM)

ESLA$-9M

JSPR$-60M

EPS (TTM)

ESLA-$0.23

JSPR-$1.11

ROE (TTM)

ESLA-25911.0%

JSPR-61887.0%

ROA (TTM)

ESLA-32876.0%

JSPR-10067.0%

ROIC (TTM)

ESLA-25911.0%

JSPR-61887.0%

Cash

ESLA$147K

JSPR$7M

Debt

ESLA$0

JSPR$0

Net Cash/Debt

ESLA$147K

JSPR$7M

Current Ratio (TTM)

ESLA0.20x

JSPR1.48x

Quick Ratio (TTM)

ESLA0.02x

JSPR1.02x

Debt/Equity (TTM)

ESLA0.00x

JSPR0.00x

Debt/Assets (TTM)

ESLA0.0%

JSPR0.0%

Interest Coverage (TTM)

ESLAN/A

JSPRN/A

Net Debt/EBITDA (TTM)

ESLA0.00x

JSPR0.00x

Beta

ESLA0.98

JSPR3.37

52W Performance

ESLA-68.5%

JSPR-76.2%

YTD Performance

ESLA-70.5%

JSPR-69.0%

% from 52W High

ESLA-87.0%

JSPR-78.8%

% from 52W Low

ESLA33.0%

JSPR81.0%

Asset Turnover (TTM)

ESLA0.00x

JSPR0.00x

FCF Yield (TTM)

ESLA-53.2%

JSPR-318.0%

Earnings Yield (TTM)

ESLA-56.8%

JSPR-167.5%

Dividend Yield (TTM)

ESLAN/A

JSPRN/A

Rule of 40

ESLA0.0

JSPR0.0

EV/GP/RG

ESLAN/A

JSPRN/A

Ticker research

View ESLA research View JSPR research

Metric	ESLA Estrella Immunopharma Inc	JSPR Jasper Therapeutics Inc
Market & Valuation
Market Cap	$18M	$19M
Enterprise Value	$17M	$12M
Price	$0.41	$0.57
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	141.63x	13.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.86x	-0.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	-81.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-32M
FCF (TTM)	$-9M	$-60M
EPS (TTM)	-$0.23	-$1.11
ROE (TTM)	-25911.0%	-61887.0%
ROA (TTM)	-32876.0%	-10067.0%
ROIC (TTM)	-25911.0%	-61887.0%
Financial Health
Cash	$147K	$7M
Debt	$0	$0
Net Cash/Debt	$147K	$7M
Current Ratio (TTM)	0.20x	1.48x
Quick Ratio (TTM)	0.02x	1.02x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.98	3.37
52W Performance	-68.5%	-76.2%
YTD Performance	-70.5%	-69.0%
% from 52W High	-87.0%	-78.8%
% from 52W Low	33.0%	81.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-53.2%	-318.0%
Earnings Yield (TTM)	-56.8%	-167.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ESLA research	View JSPR research